Analyst Reco.

May. 04 Nomura Adjusts Dr. Lal PathLabs' Price Target to INR1,860 From INR1,800, Keeps at Buy MT
Jan. 14 Kotak Securities Upgrades Dr. Lal PathLabs to Buy from Add, Price Target is INR1,760 MT
Nov. 03 Nomura Adjusts Dr. Lal PathLabs' Price Target to INR4,000 From INR3,870, Keeps at Buy MT
25-08-04 Nomura Adjusts Dr. Lal PathLabs' Price Target to INR3,870 From INR3,560, Keeps at Buy MT
25-04-28 Nomura Adjusts Dr. Lal PathLabs' Price Target to INR3,560 From INR3,315, Keeps at Buy MT
25-01-31 Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR3,315 From INR3,310 MT
24-10-25 Nomura Downgrades Dr. Lal PathLabs to Neutral From Buy, Adjusts Price Target to INR3,310 From INR3,720 MT
24-08-12 Nomura Adjusts Dr. Lal PathLabs' Price Target to INR3,720 From INR2,713, Keeps at Buy MT
24-05-14 Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 MT
24-02-05 Nomura Adjusts Dr. Lal Pathlabs’ Price Target to INR2,505 From INR2,465, Keeps at Neutral MT
23-11-06 Nomura Upgrades Dr. Lal Pathlabs to Neutral From Reduce, Adjusts Price Target to INR2,465 From INR,2002 MT
23-07-31 Nomura Downgrades Dr. Lal Pathlabs to Reduce From Neutral, Adjusts Price Target to INR2,002 From INR1,835 MT
23-05-15 Nomura Adjusts Dr. Lal PathLabs' Price Target to INR1,835 From INR1,864, Keeps at Neutral MT
23-02-06 Nomura Upgrades Dr. Lal PathLabs to Neutral From Reduce, Adjusts Price Target to INR1,864 From INR1,819 MT
No results match your criteria
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!